MedPath

Art as Creative Engagement for Stroke

Not Applicable
Completed
Conditions
Stroke
Registration Number
NCT02085226
Lead Sponsor
University of Dundee
Brief Summary

Title: A C E S Study: Can an arts based creative engagement intervention (CEI) following stroke improve psychosocial outcomes? A feasibility trial of a creative engagement intervention for inpatient rehabilitation.

This is a feasibility randomised controlled trial of a novel intervention for stroke rehabilitation examining effects of participation in visual arts activities on psychosocial outcomes after stroke.

The investigators hypothesise that participation in a visual arts based intervention (CEI) will improve stroke recovery variables, mood and self-esteem in stroke survivors receiving in-patient rehabilitation compared to viewing a portfolio of artwork.

The results of the study will inform a sample size calculation for a full trial.

Detailed Description

SUMMARY

Background: Stroke is the main cause of complex adult disability in Britain. Stroke rehabilitation is typically task orientated, focusing on physical and functional independence. Psychosocial consequences of stroke are serious and mediate recovery, influencing family relationships, community reintegration and quality of life. Therefore, improving psychosocial outcomes after stroke could improve overall recovery.

Creative arts programmes are increasingly used to address psychosocial outcomes in long-term and mental health conditions. These programmes focus on positive influences of engagement in creative art activities facilitated by artists. However, there is little research into effects of creative engagement on psychosocial outcomes after stroke.

Objectives: The purpose of this study is to:

Conduct a feasibility randomised controlled trial (RCT) to test the effects of a participatory visual arts intervention compared to art viewing on psychosocial outcomes following stroke in order to assess effect size for sample size calculation in a full RCT.

The effects of the CEI will be examined in a randomised controlled feasibility trial, which will be run at two stroke rehabilitation units in NHS Tayside and will explore the impact of the intervention on a range of psychosocial outcomes.

Patients meeting inclusion criteria will be randomised to a CEI group or an attention control group. The CEI group will receive a visual arts intervention of 4-8 sessions during in-patient rehabilitation. The control group will receive an art portfolio to view after randomisation and baseline assessment, with information about community opportunities to engage in art. The groups will be compared on selected psychosocial outcomes. Findings will indicate the potential magnitude and direction of change to allow for sample size requirements in development of a subsequent randomised control trial to examine effectiveness of the CEI.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Diagnosis of Stroke
  • Medically stable and referred for rehabilitation
  • Able to sit upright in chair
  • 3 or more weeks of rehabilitation planned
Exclusion Criteria
  • Diagnosis of Transient Ischemic Attack
  • Patinet in acute medical need
  • Patient unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Stroke Impact ScaleAssessed at end of intervention at 4 weeks
Secondary Outcome Measures
NameTimeMethod
Positive and Negative Affect Schedule (PANAS)Assessed at end of intervention at 4 weeks
Visual Analogue Self-Esteem Scale (VASES)Assessed at end of intervention at 4 weeks

Trial Locations

Locations (2)

NHS (National Health Service) Tayside, Stroke Rehab Unit, Stracathro Hospital

🇬🇧

Brechin, Angus, United Kingdom

NHS Tayside, PRI Stroke Unit, Perth Royal Infirmary

🇬🇧

Perth, Perth & Kinross, United Kingdom

NHS (National Health Service) Tayside, Stroke Rehab Unit, Stracathro Hospital
🇬🇧Brechin, Angus, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.